Original Article

Routine screening for psychosocial distress following hematopoietic stem cell transplantation

  • Bone Marrow Transplantation (2004) 35, 7783 (2005)
  • doi:10.1038/sj.bmt.1704709
  • Download Citation
Received:
Accepted:
Published online:

Abstract

The diagnosis and treatment of cancer is often associated with high levels of psychosocial distress, yet exploration of these issues is rarely included in routine oncologic care. We conducted a pilot study to evaluate the feasibility of screening for psychosocial distress after autologous and allogeneic stem cell transplantation. A total of 80 adults were enrolled in Boston, MA, USA. Subjects completed self-administered assessments prior to hospital admission, at their first clinic visit after hospital discharge, and at 100 days post transplant. Assessments included validated instruments assessing psychosocial distress and quality of life (QOL). Elevated levels of anxiety and/or depression were detected in 55% of those providing pre-transplant assessments and were associated with compromised QOL. Post transplant screening was successfully performed in 69% of subjects and identified that 44% had symptoms of depression, anxiety or post traumatic stress disorder. Pre-transplant distress was associated with detection of distress after transplantation (81 vs 13%, P<0.0001). In summary, we detected high levels of distress in transplant patients using self-administered tools. Pre-transplant distress appears to be highly predictive of distress post transplant and is a feasible marker to target screening and intervention programs.

  • Subscribe to Bone Marrow Transplantation for full access:

    $902

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    , , et al. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 1993; 15: 69–74.

  2. 2.

    , , et al. Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck 2000; 22: 799–807.

  3. 3.

    , , et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 2000; 78 (Part 1): 302–308.

  4. 4.

    , . Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000; 18: 893–903.

  5. 5.

    , , , . Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001; 84: 1011–1015.

  6. 6.

    , , et al. The prevalence of psychological distress by cancer site. Psychooncology 2001; 10: 19–28.

  7. 7.

    . NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network. Oncology (Huntington) 1999; 13: 113–147.

  8. 8.

    , . Do cancer patients really want counseling? Gen Hosp Psychiatry 1980; 2: 100–103.

  9. 9.

    , , et al. Need for supportive counselling – the professionals' vs the patients' perspective. A survey in a representative sample of 236 melanoma patients. Psychother Psychosom 1998; 67: 94–104.

  10. 10.

    , , et al. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998; 16: 1594–1600.

  11. 11.

    , , . Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology 1998; 7: 112–120.

  12. 12.

    , , . Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737–1744.

  13. 13.

    . Improving communication with cancer patients. Eur J Cancer 1999; 35: 1415–1422.

  14. 14.

    , , et al. The role of competing demands in the treatment provided primary care patients with major depression. Arch Fam Med 2000; 9: 150–154.

  15. 15.

    , , et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer 2001; 84: 179–185.

  16. 16.

    , . Awareness and barriers to use of cancer support and information resources by HMO patients with breast, prostate, or colon cancer: patient and provider perspectives. Psychooncology 2001; 10: 103–113.

  17. 17.

    , , . Doctor–patient interactions in oncology. Soc Sci Med 1996; 42: 1511–1519.

  18. 18.

    , . State and trait anxiety: an annotated bibliography. Psychol Rep 1974; 34: 519–594.

  19. 19.

    , , et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 553–571.

  20. 20.

    , . Beck depression inventory manual. Antonio, TX: The Psychological Corporation, Harcourt Brace Jovanovich, 1993.

  21. 21.

    , . The MOS social support survey. Soc Sci Med 1991; 32: 705–714.

  22. 22.

    . You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997; 4: 92–100.

  23. 23.

    , . The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.

  24. 24.

    . International experiences with the Hospital Anxiety and Depression Scale – a review of validation data and clinical results. J Psychosom Res 1997; 42: 17–41.

  25. 25.

    , , et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 363–370.

  26. 26.

    , , et al. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant 1999; 24: 1219–1228.

  27. 27.

    , , . Effectiveness of an intervention to improve primary care provider recognition of depression. Eff Clin Pract 2001; 4: 163–171.

  28. 28.

    , , , . Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12: 439–445.

  29. 29.

    , , , . Post-traumatic stress disorder in cancer: a review. Psychooncology 1999; 8: 521–537.

  30. 30.

    , , et al. Validation of the PTSD Checklist-Civilian Version in survivors of bone marrow transplantation. J Trauma Stress 1999; 12: 485–499.

  31. 31.

    , , et al. Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psychooncology 2000; 9: 69–78.

  32. 32.

    , , . Relation of psychological vulnerability factors to posttraumatic stress disorder symptomatology in bone marrow transplant recipients. Psychosom Med 2000; 62: 873–882.

  33. 33.

    , , , . SF-36 Health Survey: A Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.

  34. 34.

    , , . SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.

  35. 35.

    . Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Version 4, Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston, IL, 1997.

  36. 36.

    , , et al. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant 1998; 21: 477–486.

  37. 37.

    , , . Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67–74.

  38. 38.

    , , et al. Association of depressive syndrome and early deaths after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20: 2118–2126.

  39. 39.

    , , et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336: 542–545.

  40. 40.

    , , . Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 1997; 157: 1921–1929.

  41. 41.

    , . Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998; 66: 1718–1726.

  42. 42.

    , , . Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–2107.

  43. 43.

    , , , . Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; 2: 888–891.

  44. 44.

    , , et al. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990; 47: 720–725.

  45. 45.

    , , et al. Impact of screening for mental health concerns on health service utilization and functional status in primary care patients. Arch Intern Med 1996; 156: 2593–2599.

  46. 46.

    , , et al. Case-finding for depression in primary care: a randomized trial. Am J Med 1999; 106: 36–43.

  47. 47.

    , , et al. Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention. Quality Enhancement by Strategic Teaming. J Gen Intern Med 2001; 16: 143–149.

  48. 48.

    , , , . Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature. Psychosomatics 2000; 41: 39–52.

  49. 49.

    , , et al. Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet 2000; 355: 185–191.

  50. 50.

    , , et al. Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J Clin Oncol 2001; 19: 4117–4125.

  51. 51.

    , , et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001; 345: 1719–1726.

  52. 52.

    , , et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J 1986; 112: 653–665.

  53. 53.

    , . Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial. BMJ 1996; 313: 1517–1521.

  54. 54.

    , , et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial (comment). JAMA 2003; 289: 3106–3116.

Download references

Acknowledgements

We wish to thank Christina Caron, BA for her help with study management and data collection. This work was presented in part at the American Society of Hematology Meeting, 2003.

Author information

Affiliations

  1. Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

    • S J Lee
    • , J H Antin
    • , T Kirkpatrick
    • , L Prokop
    • , E P Alyea
    • , C Cutler
    • , V T Ho
    • , P G Richardson
    • , R L Schlossman
    • , D C Fisher
    •  & R J Soiffer
  2. Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI, USA

    • F R Loberiza
    •  & B Logan

Authors

  1. Search for S J Lee in:

  2. Search for F R Loberiza in:

  3. Search for J H Antin in:

  4. Search for T Kirkpatrick in:

  5. Search for L Prokop in:

  6. Search for E P Alyea in:

  7. Search for C Cutler in:

  8. Search for V T Ho in:

  9. Search for P G Richardson in:

  10. Search for R L Schlossman in:

  11. Search for D C Fisher in:

  12. Search for B Logan in:

  13. Search for R J Soiffer in:

Corresponding author

Correspondence to S J Lee.